ES436866A1 - Procedimiento para la preparacion de antigenos. - Google Patents

Procedimiento para la preparacion de antigenos.

Info

Publication number
ES436866A1
ES436866A1 ES436866A ES436866A ES436866A1 ES 436866 A1 ES436866 A1 ES 436866A1 ES 436866 A ES436866 A ES 436866A ES 436866 A ES436866 A ES 436866A ES 436866 A1 ES436866 A1 ES 436866A1
Authority
ES
Spain
Prior art keywords
antigens
schistosomes
agent containing
obtaining
way
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES436866A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES436866A1 publication Critical patent/ES436866A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES436866A 1974-04-29 1975-04-23 Procedimiento para la preparacion de antigenos. Expired ES436866A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2420706A DE2420706C3 (de) 1974-04-29 1974-04-29 Verfahren zum Herstellen von spezifischen Antigenen aus Schistosomen und jene enthaltendes Mittel

Publications (1)

Publication Number Publication Date
ES436866A1 true ES436866A1 (es) 1977-01-01

Family

ID=5914244

Family Applications (1)

Application Number Title Priority Date Filing Date
ES436866A Expired ES436866A1 (es) 1974-04-29 1975-04-23 Procedimiento para la preparacion de antigenos.

Country Status (16)

Country Link
JP (1) JPS50145518A (da)
AT (1) AT344329B (da)
BE (1) BE828565A (da)
CA (1) CA1052694A (da)
CH (1) CH617775A5 (da)
DE (1) DE2420706C3 (da)
DK (1) DK140044C (da)
EG (1) EG12734A (da)
ES (1) ES436866A1 (da)
FR (1) FR2268532B1 (da)
GB (1) GB1478082A (da)
IE (1) IE41024B1 (da)
IT (1) IT1049537B (da)
LU (1) LU72375A1 (da)
NL (1) NL7504853A (da)
ZA (1) ZA752717B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2356428A1 (fr) * 1976-06-29 1978-01-27 Inserm Ctre Technologie Biomed Procede de preparation d'un agent immunologique antiparasitaire, produit obtenu et son application
FR2601037B1 (fr) * 1986-07-03 1988-10-21 Pasteur Institut Peptide presentant des proprietes antigeniques isole de la proteine 28 kd de s. mansoni et son procede d'isolement, anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et application de celui-ci dans l'induction de la synthese d'anticorps neutralisants

Also Published As

Publication number Publication date
ZA752717B (en) 1976-03-31
DK140044B (da) 1979-06-11
IE41024L (en) 1975-10-29
FR2268532B1 (da) 1980-01-25
IE41024B1 (en) 1979-10-10
GB1478082A (en) 1977-06-29
DE2420706A1 (de) 1975-10-30
DK184575A (da) 1975-10-30
ATA325475A (de) 1977-11-15
LU72375A1 (da) 1977-02-03
IT1049537B (it) 1981-02-10
CA1052694A (en) 1979-04-17
FR2268532A1 (da) 1975-11-21
DK140044C (da) 1979-11-12
AT344329B (de) 1978-07-10
CH617775A5 (en) 1980-06-13
EG12734A (en) 1979-06-30
BE828565A (fr) 1975-10-29
DE2420706C3 (de) 1979-11-22
JPS50145518A (da) 1975-11-21
DE2420706B2 (de) 1979-03-22
NL7504853A (nl) 1975-10-31

Similar Documents

Publication Publication Date Title
BE840616A (fr) Dispositif pour la sterilisation par coagulation transuterine du tissu entre les oviductes et l'uterus
ES2054696T3 (es) Agente viral de la hepatitis nanb, antigen y reactivo inmunologico.
ES8200082A1 (es) Procedimiento para esterilizar un agente de contraste de ra-yos x de m-carboxamido-o-yodo-n-(b-hidroxialcohil)-anilina.
ES398962A1 (es) Un procedimiento para la preparacion de una composicion de enzima.
JPS5549393A (en) Novel tissue protein pp8
ES379641A1 (es) Procedimiento de produccion de antigenos inactivos para preparados farmaceuticos.
ES336810A1 (es) Un metodo para producir una cepa de celulas.
ES436866A1 (es) Procedimiento para la preparacion de antigenos.
SE408412B (sv) Forfarande for framstellning av l-3-(3,4-dihydroxi-fenyl)-2-metyl-alanin-peptider med blodtryckssenkande egenskaper
ES449941A1 (es) Un metodo de preparacion de un nuevo virus vivo de la rabia.
Seidel The life cycle in vitro of Hymenolepis microstoma (Cestoda)
SE7510775L (sv) Fenoxialkankarbonsyraamider och forfarande for framstellning derav
Carrel An Address On The Method Of Tissue Culture And Its Bearing On Pathological Problems
BE782646A (fr) Procede de scission enzymatique de penicillines ''naturelles'' et de synthese enzymatique de penicillines ''semi-synthetiques'' au moyen d'un acylase insoluble et de scission enzymatique ou de synthese de composesayant des proprietes therapeutiques analogues
ES387885A1 (es) Metodo de preparacion de sulfato de condroitina.
McFadzean et al. Bacterial endocarditis due to Salmonella sp.(type sendai) with recovery
ES424506A1 (es) Un sistema para realizar pruebas sanguineas de laboratorio.
LEVINE et al. Streptobacillus moniliformis bacteremia with minor clinical manifestations
FR2423223A1 (fr) Vaccin et dose a injecter pour l'immunotherapie d'une maladie neoplasique
SE8005921L (sv) Nya foreningar med karcinostatisk och immunostimulerande aktivitet samt forfarande for framstellning derav
GB806950A (en) Production of pharmaceutical preparations
Boroff et al. Destruction of Sulfonamide Inhibition Present in Sera by Soil Bacillus (Mirick)
BE795293A (fr) Procede de culture en masse de virus de la fievre aphteuse
FR1171397A (fr) Procédé et appareil pour l'introduction de matières plastiques, notamment de chair à saucisses, dans des enveloppes, par exemple dans des boyaux
BE815777A (fr) Produit pour le traitement medical des maladies infectieuses en particulier pour les maladies virulentes en medecine humaine et animale